ALKS Exercise Disclosure
Hopkinson Craig C. · SEC Form 4 · Filed Sep 1, 2026
Exercise
Calculated transaction value
$0
Hopkinson Craig C. EVP R&d, Chief Medical Officer
ALKS
Alkermes Inc
ALKS
Transaction date
Sep 1, 2026
Public filing date
Sep 1, 2026
Filing lag
Filed same day
ALKS daily price context
Close on/before transaction
$47.2
Sep 1, 2026
Close before public filing
$46.99
Aug 31, 2026
Return since public filing
-7.64%
Through Sep 21, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Ordinary Shares
- Quantity / price
- 5,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001520262-26-000118
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$545.82K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Alkermes Plc. ALKS | Exercise | Sep 1, 2026 | $122.95K |
| Alkermes Plc. ALKS | Sale | Sep 1, 2026 | $422.87K |
| Alkermes Plc. ALKS Current | Exercise | Sep 1, 2026 | $0 |